About the Authors
- Reza Yaesoubi
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: reza.yaesoubi@yale.edu
Affiliation Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America
- Ted Cohen
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
Affiliation Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America
- Katherine Hsu
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Massachusetts Department of Public Health, Boston, Massachusetts, United States of America
- Thomas L. Gift
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Sancta B. St. Cyr
-
Roles Data curation, Writing – review & editing
Affiliation Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Joshua A. Salomon
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
Affiliation Department of Health Policy, Stanford University School of Medicine, Palo Alto, California, United States of America
- Yonatan H. Grad
-
Roles Conceptualization, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: RY, TC, JAS, and YHG received funding from the National Institute of Health and the U.S. Centers for Disease Control and Prevention. TLG and SBS are employed by the U.S. Centers for Disease Control and Prevention. YHG has received research funding from Pfizer and Merck for unrelated work and has received consulting fees from GSK.